More than six months after Kentucky lawmakers passed legislation allowing limited trials for cannabidiol epilepsy treatments, doctors have not been able to begin them.
Kosair Children’s Hospital Epilepsy Monitoring Unit Director Karen Skjei says she is waiting on FDA approval for the trials. She says one potential obstacle is if the agency requires trials with animals before testing the treatment for people.
A new law that goes into effect tomorrow will help patients with chronic health issues maintain their standard of living. The law allows doctors to show that a long-prescribed medicine would be the best for a patient.